Pelvic exenteration: a critical analysis of a ten-year experience with the use of the team approach.
D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D005260:Female; D005833:Genital Neoplasms, Female / Q000601:surgery*; D006801:Humans; D008545:Melanoma / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D008649:Mesonephroma / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D008722:Methods; D010385:Pelvic Exenteration; D012004:Rectal Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D014625:Vaginal Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery